English, , 4,583kb
This document is the report of the OECD Workshop on Exposure Assessment and Exposure Mitigation, which was held on 20 October 2008, in Frankfurt, Germany. This report includes a summary of the plenary presentations as w
This conference, which took place in Paris on 15-17 July 2009, will significantly contribute to accelerating OECD’s current efforts for fostering “green” and innovation-led growth in nanotechnology.
English, , 288kb
This document should be seen as a component of the overall work of the programme on the safety of manufactured nanomaterials, which is been developed by OECD’s WPMN.
An OECD workshop hosted by Canada will be held on July 23-24, 2009 in Montréal, Québec immediately after the 6th World Congress on Industrial Biotechnology and Bio-processing to discuss progress over the past 5 years in the methodologies used for sustainability assessment of bio-based products.
Given the current low level of nanotechnology monitoring, the objective of this paper is to provide a comprehensive overview of nanotechnology developments globally through a systematic and critical analysis of available and comparable indicators and statistics.
This document presents the OECD Definitions of Information Economy Products: the ICT products definition and Content and media products definition.
A new OECD report, The Bioeconomy to 2030: Designing a Policy Agenda, examines the role of biotechnology in the global economy over the next two decades and outlines policies that could maximize its benefits.
This report warns that innovation risks being hit hard by the economic crisis as the capital to finance it grows scarce.
English, , 2,471kb
This report provides practical recommendations for facilitating an efficacious dialogue with society on scientific issues.
English, , 2,570kb
The 2009 edition brings together the latest available economic and activity data on biotechnology and innovation for 22 OECD members and four non-member countries. It builds on the extensive work of the OECD and national experts to improve the comparability of biotechnology statistics.